COVID - 19 Vaccination Update - Day 500 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 41 Second

Posted On: 30 MAY 2022 8:21 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 193.43 Crore (1,93,43,51,597) today. More than 11 lakh (11,67,191) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10406961
	2^nd Dose	10040071
	Precaution Dose	5222188
FLWs	1^st Dose	18419213
	2^nd Dose	17584160
	Precaution Dose	8725305
Age Group 12-14 years	1^st Dose	33902151
	2^nd Dose	16330065
Age Group 15-18 years	1^st Dose	59469313
	2^nd Dose	45714209
Age Group 18-44 years	1^st Dose	557145123
	2^nd Dose	490038179
	Precaution Dose	874675
Age Group 45-59 years	1^st Dose	203248965
	2^nd Dose	190854779
	Precaution Dose	1399944
Over 60 years	1^st Dose	127089281
	2^nd Dose	119037881
	Precaution Dose	18849134
Cumulative 1^st dose administered		1009681007
Cumulative 2^nd dose administered		889599344
Precaution Dose		35071246
Total		1934351597

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 30^th May, 2022 (500^th Day)
HCWs	1^st Dose	54
	2^nd Dose	651
	Precaution Dose	13874
FLWs	1^st Dose	248
	2^nd Dose	1129
	Precaution Dose	65098
Age Group 12-14 years	1^st Dose	92070
	2^nd Dose	232919
Age Group 15-18 years	1^st Dose	28740
	2^nd Dose	93023
Age Group 18-44 years	1^st Dose	32020
	2^nd Dose	273064
	Precaution Dose	29611
Age Group 45-59 years	1^st Dose	5707
	2^nd Dose	59623
	Precaution Dose	22451
Over 60 years	1^st Dose	3860
	2^nd Dose	38979
	Precaution Dose	174070
Cumulative 1^st dose administered		162699
Cumulative 2^nd dose administered		699388
Precaution Dose		305104
Total		1167191

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.